Kamau Therapeutics is a clinical-stage, next-generation gene correction company harnessing high efficiency targeted gene integration to develop a new class of therapies with the aim to cure a wide range of serious and life-threatening diseases.
With roots in Kenyan and Polynesian cultures, the name ‘Kamau’ means silent warrior or the spirit of perseverance, respectively. This name serves as a testament to the strength of those battling serious genetic diseases and embodies our commitment to developing the definitive generation of curative genetic medicines for patients.
